Erschienen in:
01.06.2013
Taurine Enhances Antinociception Produced by a COX-2 Inhibitor in an Inflammatory Pain Model
verfasst von:
Beatriz de Rienzo-Madero, Ulises Coffeen, Karina Simón-Arceo, Francisco Mercado, Orlando Jaimes, Lucía Magis-Weinberg, Bernardo Contreras, Francisco Pellicer
Erschienen in:
Inflammation
|
Ausgabe 3/2013
Einloggen, um Zugang zu erhalten
Abstract
The temporal activation of the sensory systems, especially in pain, determines intermediate states that define the future of the response to sensory stimulation. In this work, we interfere pharmacologically with those states that produce peripheral and central sensitisation after an acute inflammatory process, inhibiting at the periphery the COX-2 with celecoxib and using taurine (glycine A receptor agonist) for central pain relief. We tested the paw withdrawal reflex latencies to thermo- and mechanonociception after the induction of an acute inflammatory process with carrageenan. Celecoxib at low doses [0.13 and 1.3 mg/kg, intraperitoneal (i.p.)] in combination with taurine (300 mg/kg, i.p.) produces a decrease of the nociceptive response in thermo- and mechanonociception, as compared with the effect of both drugs alone. We propose that the enhancement of the analgesic effect of celecoxib in combination with taurine could be due the simultaneous action of these drugs at both, peripheral and central levels.